Abstract
Although distinct pathological stages of breast cancer have been described, the molecular differences among these stages are largely unknown. Here, through the combined use of laser capture microdissection and DNA microarrays, we have generated in situ gene expression profiles of the premalignant, preinvasive, and invasive stages of human breast cancer. Our data reveal extensive similarities at the transcriptome level among the distinct stages of progression and suggest that gene expression alterations conferring the potential for invasive growth are already present in the preinvasive stages. In contrast to tumor stage, different tumor grades are associated with distinct gene expression signatures. Furthermore, a subset of genes associated with high tumor grade is quantitatively correlated with the transition from preinvasive to invasive growth.
MeSH Terms
Breast Neoplasms/genetics,pathology
Disease Progression
Enzymes/genetics
Epithelial Cells/pathology
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Image Processing, Computer-Assisted
In Situ Hybridization
Neoplasm Proteins/genetics
Neoplasm Staging
Polymerase Chain Reaction
Chemicals
Enzymes
Neoplasm Proteins
Authors & Affiliations
19 authors, click to expand affiliations / ORCID
Ma Xiao-Jun
Applied Genomics Division, Arcturus, 2715 Loker Avenue West, Carlsbad, CA 92008, USA.
Salunga Ranelle
Tuggle J Todd
Gaudet Justin
Enright Edward
McQuary Philip
Payette Terry
Pistone Maria
Stecker Kimberly
Zhang Brian M
Zhou Yi-Xiong
Varnholt Heike
Smith Barbara
Gadd Michelle
Chatfield Erica
Kessler Jessica
Baer Thomas M
Erlander Mark G
Sgroi Dennis C
References (21)
21 references, click to expand
-
In vivo gene expression profile analysis of human breast cancer progression.
Cancer Res. 1999 Nov 15;59(22):5656-61
PMID: 10582678
-
The hallmarks of cancer.
Cell. 2000 Jan 7;100(1):57-70
PMID: 10647931
-
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
Br J Cancer. 2001 Sep 14;85(6):869-74
PMID: 11556839
-
Gene expression profiling predicts clinical outcome of breast cancer.
Nature. 2002 Jan 31;415(6871):530-6
PMID: 11823860
-
Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.
Nucleic Acids Res. 2002 Feb 15;30(4):e15
PMID: 11842121
-
Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
Cancer. 2002 Apr 15;94(8):2134-42
PMID: 12001109
-
A new era in the diagnosis of breast cancer.
Surg Oncol Clin N Am. 2000 Apr;9(2):233-77
PMID: 10757844
-
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement.
Mod Pathol. 2000 Jul;13(7):730-5
PMID: 10912931
-
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192).
Am J Clin Oncol. 2001 Feb;24(1):10-8
PMID: 11232942
-
Histological and biological evolution of human premalignant breast disease.
Endocr Relat Cancer. 2001 Mar;8(1):47-61
PMID: 11350726
-
Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays.
Am J Pathol. 2001 Jun;158(6):2005-10
PMID: 11395378
-
On the origin and progression of ductal carcinoma in the human breast.
J Natl Cancer Inst. 1973 May;50(5):1111-8
PMID: 4123242
-
Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia.
Hum Pathol. 1992 Oct;23(10):1095-7
PMID: 1328030
-
Ductal carcinoma in situ: a proposal for a new classification.
Semin Diagn Pathol. 1994 Aug;11(3):167-80
PMID: 7831528
-
Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
Cancer Res. 1995 Feb 1;55(3):467-71
PMID: 7834608
-
Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14036-40
PMID: 8943056
-
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
Science. 1996 Dec 20;274(5295):2057-9
PMID: 8953032
-
The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
Cancer Res. 1998 Apr 15;58(8):1650-3
PMID: 9563477
-
Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
J Natl Cancer Inst. 1998 May 6;90(9):697-703
PMID: 9586667
-
Gene expression profiles of laser-captured adjacent neuronal subtypes.
Nat Med. 1999 Jan;5(1):117-22
PMID: 9883850
-
A SAGE (serial analysis of gene expression) view of breast tumor progression.
Cancer Res. 2001 Aug 1;61(15):5697-702
PMID: 11479200